1. Prospects for Pharmacological Male Contraception

   • Stephen A. Matlin

   Leading Article 31 October 2012 Pages: 851 - 863

2. Angiotensin Converting Enzyme Inhibitors in Raynaud’s Phenomenon

   • V. F. Challenor

   Review Article 31 October 2012 Pages: 864 - 867

3. Pharmacological Management of Hypertension in Paediatric Patients

   • Kenneth Miller

   Review Article 31 October 2012 Pages: 868 - 887

4. Botulinum Toxin in Clinical Practice

   • Andrew J. Hughes

   Practical Therapeutics 31 October 2012 Pages: 888 - 893

5. Dornase Alfa

   • Harriet M. Bryson
   • Eugene M. Sorkin

   Drug Evaluation 31 October 2012 Pages: 894 - 906

6. Piroxicam-β-Cyclodextrin

   • C. Rhoda Lee
   • Julia A. Balfour

   Drug Evaluation 31 October 2012 Pages: 907 - 929

7. Erratum to Acarbose: an update of its pharmacology and therapeutic use in diabetes mellitus

   • J. A. Balfour
   • D. McTavish

   Erratum 31 October 2012 Pages: 929 - 929

8. Erratum to Teicoplanin: a reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

   • R. N. Brogden
   • D. H. Peters

   Erratum 31 October 2012 Pages: 929 - 929

9. Leuprorelin

   • Greg L. Plosker
   • Rex N. Brogden

   Drug Evaluation 31 October 2012 Pages: 930 - 967